Sarah Chisolm

ORCID: 0000-0002-9538-1170
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Dermatology and Skin Diseases
  • Allergic Rhinitis and Sensitization
  • Contact Dermatitis and Allergies
  • Nail Diseases and Treatments
  • Autoimmune Bullous Skin Diseases
  • Urticaria and Related Conditions
  • Cancer, Stress, Anesthesia, and Immune Response
  • Asthma and respiratory diseases
  • Food Allergy and Anaphylaxis Research
  • Digital Imaging in Medicine
  • Indoor Air Quality and Microbial Exposure
  • Dermatological and Skeletal Disorders
  • Eosinophilic Esophagitis
  • Inflammatory Myopathies and Dermatomyositis
  • Medicine and Dermatology Studies History
  • Nonmelanoma Skin Cancer Studies
  • Patient Dignity and Privacy
  • Eosinophilic Disorders and Syndromes
  • Electronic Health Records Systems
  • Ocular Surface and Contact Lens
  • Infection Control in Healthcare
  • Plant and fungal interactions
  • Gastrointestinal motility and disorders
  • Adrenal Hormones and Disorders
  • Pain Mechanisms and Treatments

Grady Memorial Hospital
2020-2024

Emory University
2018-2024

Veterans Health Administration
2020-2024

Atlanta VA Health Care System
2022

VA Southeast Network
2020

Stanford University
2018

Chronic pruritus, defined as itch experienced for 6 weeks or longer, affects approximately 22% of people in their lifetime. Approximately 1% physician visits are the chief concern chronic pruritus. pruritus is associated with adverse outcomes, including impaired sleep and reduced quality life.

10.1001/jama.2024.4899 article EN JAMA 2024-05-29

The association between dermatomyositis and internal malignancy is well established, but there little consensus about the methods of cancer screening that should be utilized. We wished to analyze prevalence yield selected modalities in patients with dermatomyositis. performed a retrospective analysis 2 large US cohorts comprising 400 patients. measured frequency tests used search for malignancy. Patients biopsy-confirmed were identified. Prespecified clinical laboratory factors tested For...

10.1097/md.0000000000009639 article EN cc-by-nc Medicine 2018-01-01

Chronic prurigo (CPG) is a highly burdensome pruritic disease characterized by chronic itch, prolonged scratching behavior and the development of localized or generalized hyperkeratotic pruriginous lesions. Neuronal sensitization an itch-scratch cycle contribute to augmentation pruritus chronicity disease. We provide here first international guideline for rational diagnostic therapeutic approach CPG. Recommendations are based on available evidence expert opinion. The diagnosis CPG made...

10.1097/itx.0000000000000042 article EN cc-by-nc-nd Itch 2020-10-01

Background The coronavirus infectious disease 2019 pandemic has resulted in health care workers donning personal protective equipment (PPE) for extended periods. Objectives aims of the study were to review facial PPE (surgical masks and N95 respirators) ingredients, identify resterilization techniques, recommend strategies prevention management PPE–related dermatoses. Methods Twenty-one (11 respirators, 10 surgical masks) reviewed. Resterilization techniques identified. Personal...

10.1097/der.0000000000000699 article EN Dermatitis 2020-12-03

Importance: Neuropathic pruritus is a debilitating condition lacking uniform approach to nomenclature and diagnosis. Objective: A panel of dermatologist experts in was convened develop definitions, diagnostic recommendations, treatment guidelines for neuropathic pruritus. Evidence review: roundtable discussion 10 conducted on November 3, 2021, via the Zoom platform. This study follows Standards Reporting Qualitative Research reporting qualitative studies. systematic review prior literature...

10.1097/itx.0000000000000073 article EN cc-by-nc-nd Itch 2023-12-27

10.5070/d329160223 article EN cc-by-nc-nd Dermatology Online Journal 2023-02-25

Abstract Pruritus is a hallmark symptom of atopic dermatitis (AD) and known to worsen patients’ health-related quality life. Lebrikizumab high-affinity monoclonal antibody which binds IL-13, dominant cytokine implicated in AD. This study includes data from two Phase 3 randomized controlled trials assessing the efficacy safety lebrikizumab patients with moderate-to-severe AD, ADvocate1 (NCT04146363) ADvocate2 (NCT04178967). We report post-hoc analysis quantify effect vs placebo on Dermatology...

10.1093/ced/llae541 article EN cc-by-nc Clinical and Experimental Dermatology 2024-12-16

Allergic contact dermatitis (ACD) may occur secondary to topical antifungals containing potential allergens in their vehicles. Variation of allergenic ingredients among commonly used antifungal creams (AFCs) has not been well characterized.The study goal was assess the frequency 4 AFCs.Topical AFCs (clotrimazole, ketoconazole, miconazole, and terbinafine) were selected, ingredient lists for these products obtained from US Food Drug Administration's Online Label Repository via a proprietary...

10.1097/der.0000000000000588 article EN Dermatitis 2020-03-25

Atopic dermatitis (AD) and bullous pemphigoid (BP) are inflammatory skin diseases in which patients often report intense pruritus significant quality of life (QOL) impact. Although they have differences classical presentation (eczematous eruption versus urticaria blisters) population characteristics (young-to middle aged persons vs. elderly), early stages BP can appear similar to AD clinically histologically. We wanted explore whether there were similarities or QOL Our observational cohort...

10.1016/j.jid.2019.06.066 article EN publisher-specific-oa Journal of Investigative Dermatology 2019-08-21

Abstract not available.

10.25251/skin.5.supp.30 article FR SKIN The Journal of Cutaneous Medicine 2021-01-01
Coming Soon ...